Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 17.19 is 60% above its 3-year average of 10.74, around the middle of its 3-year range (0.00–24.76).
As of the fiscal period ended Tuesday, June 30, 2026. 5.74% above its 12-month average of 16.25.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 17.19.
CURRENT RATIO
17.19
CURRENT RATIO AVG TTM
16.25
CURRENT RATIO AVG 3Y
13.90
CURRENT RATIO AVG 5Y
N/A
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+5.74%
CURRENT VS 3Y AVG
+23.65%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.76
median of 873 covered companies
CURRENT VS SECTOR MEDIAN
+357.14%
vs the sector median at left
Market Cap
$235.97M
Current Ratio
21.72
TTM Avg
10.47
3Y Avg
8.50
5Y Avg
9.09
Market Cap
$235.66M
Current Ratio
1.43
TTM Avg
1.27
3Y Avg
1.29
5Y Avg
1.36
Market Cap
$235.08M
Current Ratio
48.62
TTM Avg
31.63
3Y Avg
25.23
5Y Avg
22.81
Market Cap
$239.02M
Current Ratio
8.28
TTM Avg
3.73
3Y Avg
7.03
5Y Avg
8.20
Market Cap
$241.34M
Current Ratio
9.97
TTM Avg
9.81
3Y Avg
16.34
5Y Avg
20.09
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| BioAge Labs Inc. (BIOA) | $236.82M | 17.19 | 16.25 | 13.90 | N/A |
| Invivyd, Inc. (IVVD)vs › | $237.57M | 5.87 | 4.43 | 7.10 | 7.89 |
| SIGA Technologies, Inc. (SIGA)vs › | $235.97M | 21.72 | 10.47 | 8.50 | 9.09 |
| Akebia Therapeutics, Inc. (AKBA)vs › | $235.66M | 1.43 | 1.27 | 1.29 | 1.36 |
| Utah Medical Products, Inc. (UTMD)vs › | $235.08M | 48.62 | 31.63 | 25.23 | 22.81 |
| High Tide Inc. (HITI)vs › | $239.01M | 1.50 | 1.39 | 1.25 | 1.14 |
| Century Therapeutics, Inc. (IPSC)vs › | $239.02M | 8.28 | 3.73 | 7.03 | 8.20 |
| InflaRx N.V. (IFRX)vs › | $232.72M | 8.22 | 4.59 | 5.79 | 6.14 |
| Quantum-Si incorporated (QSI)vs › | $241.34M | 9.97 | 9.81 | 16.34 | 20.09 |
| Q32 Bio Inc. (QTTB)vs › | $241.39M | 20.30 | 4.91 | 4.89 | 6.73 |
Current Ratio
17.19
Quick Ratio
17.19
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 17.19 |
| 2026-03-31 | 24.76 |
| 2025-12-31 | 14.24 |
| 2025-09-30 | 11.87 |
| 2025-06-30 | 13.21 |
| 2025-03-31 | 13.68 |
| 2024-12-31 | 12.86 |
| 2024-09-30 | 17.63 |
| 2024-06-30 | 12.61 |
| 2024-03-31 | 11.81 |
| 2023-12-31 | 0.44 |
| 2023-09-30 | 0.00 |
| 2023-06-30 | 0.00 |
| 2023-03-31 | 0.00 |
